Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-13 5:17 pm Unchanged | 13G | GRI BIO INC GRI | Altium Capital Management LP | 1,269,210 4.99% | 0 (Unchanged) | View |
| 2023-05-02 8:23 pm Purchase | 13G | GRI BIO INC GRI | Altium Capital Management LP | 1,269,210 9.99% | 1,269,210 (New Position) | View |
| 2023-05-02 4:05 pm Purchase | 13G | GRI BIO INC GRI | TEP Biotech LLC | 204,909 6.93% | 204,909 (New Position) | View |
| 2023-04-25 4:19 pm Purchase | 13D | GRI BIO INC GRI | Chaturvedi Vipin | 172,189 5.82% | 172,189 (New Position) | View |
| 2023-04-25 4:19 pm Purchase | 13D | GRI BIO INC GRI | Agro Albert | 172,189 5.82% | 172,189 (New Position) | View |
| 2023-04-25 4:18 pm Purchase | 13D | GRI BIO INC GRI | Hertz Walter Marc | 385,510 13.04% | 385,510 (New Position) | View |
| 2023-02-13 4:30 pm Sale | 13G | VALLON PHARMACEUTICALS INC VLON | Lind Global Fund II LP | 7,500 0.1% | -1,077,000 (-99.31%) | View |
| 2023-01-30 09:09 am Sale | 13G | VALLON PHARMACEUTICALS INC VLON | BIGGER CAPITAL FUND L P | 0 0% | -740,000 (Position Closed) | View |
| 2022-12-27 11:09 am Sale | 13G | VALLON PHARMACEUTICALS INC VLON | Markey John | 0 0% | -849,489 (Position Closed) | View |
| 2022-09-28 5:47 pm Purchase | 13G | VALLON PHARMACEUTICALS INC VLON | Markey John | 849,489 8.1% | 849,489 (New Position) | View |
| 2022-05-23 5:00 pm Purchase | 13G | VALLON PHARMACEUTICALS INC VLON | Lind Global Fund II LP | 1,084,500 9.9% | 1,084,500 (New Position) | View |
| 2022-05-23 4:30 pm Purchase | 13G | VALLON PHARMACEUTICALS INC VLON | BIGGER CAPITAL FUND L P | 740,000 5.3% | 740,000 (New Position) | View |
| 2022-05-18 12:34 pm Purchase | 13G | VALLON PHARMACEUTICALS INC VLON | Lincoln Park Capital Fund LLC | 1,050,232 9.99% | 1,050,232 (New Position) | View |
| 2022-02-17 3:29 pm Purchase | 13G | VALLON PHARMACEUTICALS INC VLON | Malnik Dov | 509,781 7.5% | 509,781 (New Position) | View |
| 2022-02-14 9:41 pm Purchase | 13G | VALLON PHARMACEUTICALS INC VLON | Arcturus Therapeutics Holdings Inc. ARCT | 843,750 12.38% | 843,750 (New Position) | View |
| 2021-03-15 7:51 pm Unchanged | 13D | VALLON PHARMACEUTICALS INC VLON | SALMON Pharma GmbH | 1,523,797 22.4% | 0 (Unchanged) | View |
| 2021-02-12 6:02 pm Purchase | 13D | VALLON PHARMACEUTICALS INC VLON | SALMON Pharma GmbH | 1,523,797 20.5% | 1,523,797 (New Position) | View |